Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Lauren M. Curtis"'
Autor:
Sencer Goklemez, Lauren M. Curtis, MD, Alao Hawwa, MD, Alexander Ling, MD, Daniele Avila, CRNP, Theo Heller, MD, Steven Z. Pavletic, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 1, Iss 2, Pp 198-201 (2017)
Calcineurin inhibitors (CNIs) are effective agents used for prevention of graft-vs-host disease after allogeneic hematopoietic stem cell transplant or for organ rejection in solid-organ transplant. However, CNIs have a wide range of adverse effects t
Externí odkaz:
https://doaj.org/article/d0ed3317778b4d889e37f1cd02b9ee9a
Autor:
Lauren M. Curtis, Manuel B. Datiles, Seth M. Steinberg, Sandra A. Mitchell, Rachel J. Bishop, Edward W. Cowen, Jacqueline Mays, John M. McCarty, Zoya Kuzmina, Filip Pirsl, Daniel H. Fowler, Ronald E. Gress, Steven Z. Pavletic
Publikováno v:
Haematologica, Vol 100, Iss 9 (2015)
Ocular chronic graft-versus-host disease is one of the most bothersome common complications following allogeneic hematopoietic stem cell transplantation. The National Institutes of Health Chronic Graft-versus-Host Disease Consensus Project provided e
Externí odkaz:
https://doaj.org/article/cc4e1de92dd54006a7d7e52dce4c497b
Autor:
Eduard Schulz, Noa G. Holtzman, Alen Ostojic, Filip Pirsl, Seth M. Steinberg, Lauren M. Curtis, Brian C. Shaffer, Theo Heller, Ashley Carpenter, David Beshensky, Jeffrey S. Rubin, Ronald E. Gress, Dr. Steven Z. Pavletic
Publikováno v:
Transplantation and Cellular Therapy. 29:S258-S259
Autor:
Noa G. Holtzman, Dr. Annie P. Im, Alen Ostojic, Lauren M. Curtis, Laura Parsons-Wandell, Arlene Berman, Jeanette Nashed, Cody J. Peer, Annieka Reno, William Douglas Figg, M. Teresa Magone, Edward W. Cowen, Jacqueline W. Mays, Fran T. Hakim, Jeremy J. Rose, Seth M. Steinberg, Marie Pouzolles, Naomi Taylor, Dr. Steven Z. Pavletic
Publikováno v:
Transplantation and Cellular Therapy. 29:S251-S252
Autor:
Lauren M. Curtis, Galen O. Joe, Judy Baruffaldi, Ana Zelic Kerep, Steven Z. Pavletic, Ann Berger, Laura Parsons-Wandell, Filip Pirsl, Noa G. Holtzman, Seth M. Steinberg, Claire L. Ruben, Manuel B. Datiles, Edward W. Cowen, Jacqueline W. Mays, Sandra A. Mitchell
Publikováno v:
Bone marrow transplantation
Malignancy relapse remains a major barrier to treatment success in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) markedly reduces hematologic malignancy relapse risk, but rela
Autor:
Lauren M. Curtis, Annie Im, Frances T. Hakim, Noa G. Holtzman, Jacqueline Parkin, William D. Figg, Cody J. Peer, William R. Moore, Steven Z. Pavletic, Laura Parsons-Wandell, Jeremy J. Rose
Publikováno v:
Blood. 138:1815-1815
Introduction Bronchiolitis Obliterans Syndrome (BOS) is a rare but devastating complication of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) and is associated with a high morbidity and mortality. T
Autor:
Tiffani Taylor, Jacqueline W. Mays, Nataliya P. Buxbaum, Steven Z. Pavletic, Kristin Baird, Sandra A. Mitchell, Daniel H. Fowler, Annie Im, Lauren M. Curtis, Seth M. Steinberg, Edward W. Cowen, Ronald E. Gress, Dominique C. Pichard, Daniele Avila, Filip Pirsl
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:1980-1988
Predicting the duration of systemic therapy in patients with chronic graft-versus-host disease (cGVHD) is of critical clinical importance when counseling patients and for treatment planning. cGVHD characteristics associated with this outcome have not
Autor:
Jeremy J. Rose, Jeannette Nashed, Lauren M. Curtis, William D. Figg, Frances T. Hakim, Noa G. Holtzman, Laura Parsons-Wandell, Amisha V. Barochia, Cody J. Peer, Steven Z. Pavletic, Annie Im
Publikováno v:
Blood. 136:18-19
Introduction Bronchiolitis Obliterans Syndrome (BOS) is a rare but devastating complication of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) and is associated with a high morbidity and mortality. T
Autor:
Theo Heller, Daniele Avila, Sencer Goklemez, Lauren M. Curtis, Alexander Ling, Alao Hawwa, Steven Z. Pavletic
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 1, Iss 2, Pp 198-201 (2017)
Calcineurin inhibitors (CNIs) are effective agents used for prevention of graft-vs-host disease after allogeneic hematopoietic stem cell transplant or for organ rejection in solid-organ transplant. However, CNIs have a wide range of adverse effects t
Autor:
Edward W. Cowen, Steven Z. Pavletic, Lauren M. Curtis, Alen Ostojić, Liang Cao, Filip Pirsl, Annie P. Im, Frances T. Hakim, Jacqueline W. Mays, Seth M. Steinberg, Noa G. Holtzman, Judy Baruffaldi, Sencer Goklemez, Jeremy J. Rose, Sandra A. Mitchell
Publikováno v:
Am J Hematol
Chronic graft-versus-host disease (cGVHD) is the leading late complication after allogeneic hematopoietic stem cell transplantation (HSCT). Many patients receive multiple lines of systemic therapy until cGVHD resolves, but about 15% remain on systemi